United States· US:70518-4050_3fa16c36-fa12-db93-e063-6394a90ad2bf
Potassium Chloride
A kalium, kombinationen product containing potassium chloride, registered in United States by REMEDYREPACK INC.. The same ATC class is registered in 3 of our 19 countries.
Checked against FDA National Drug Code directory (United States) on
Informational only — not a medical device.
Where it is registered
Kalium, kombinationen is registered in 3 of 19 countries.
Countries holding a registration under ATC A12BA51 (kalium, kombinationen), each read from that country’s own register.
- This record: United States, from FDA National Drug Code directory (United States)
- 3 of them publish a price we can compare per daily dose
Kalium, kombinationen · ATC A12BA51
3 / 19 countries
- Czechiaprice
- Finlandprice
- United Statesprice
The record
At a glance
FDA National Drug Code directory (United States)- Active substance
- Potassium Chloride
- Manufacturer
- REMEDYREPACK INC.
- Country
- United States (US)
- ATC code
- A12BA51
- ATC class
- Kalium, Kombinationen
- Reimbursed
- Not published by this register
- Source register
- FDA National Drug Code directory (United States)
- Last checked
- June 3, 2026
Packs & prices · 2
- ndc11705184050030 CAPSULE, EXTENDED RELEASE in 1 BLISTER PACK (70518-4050-0)
- ndc117051840501100 POUCH in 1 BOX (70518-4050-1) / 1 CAPSULE, EXTENDED RELEASE in 1 POUCH (70518-4050-2)
Regulatory notes
Same medicine, other countries
Kalium, kombinationen in 16 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- United KingdomAad K 600mg (8mmol) Slow Release tabletsEssential-Healthcare Ltd
- BelgiumAccusol 35 Kalium 2 mmol/lNikkiso Belgium
- CzechiaARDEAELYTOSOL CONC. KALIUMCHLORID 7,45%ARDEAPHARMA, a.s., Ševětín
- FinlandAddex-KaliumkloridFresenius Kabi AB
- NorwayAcalka pharmaprimFerrer Internacional S.A.
- Japanグルコン酸カリウムサンファーマ
- FranceCHLORURE DE POTASSIUM B. BRAUN 10 % (0,10 g/ml), solution à diluer pour perfusionB BRAUN MELSUNGEN
- NetherlandsKacital 1080 mg, tabletten met gereguleerde afgifteXGX Pharma ApS
Authorised across Europe · EMA
The same active substance is authorised in 30 EEA countries. Names it is sold under:
- Austria · Kacital, Kaliumchlorid B. Braun
- Belgium · Chlorure De Potassium Noridem, Kacital
- Bulgaria · Калиев Хлорид Браун, Нефромелтар
- Cyprus · Sopa-K, Καλιο Χλωριουχο Demo
- Czechia · Ardeaelytosol, Kalium Chloratum Biomedica
- Germany · 1 M-Kaliumchlorid-Lösung Deltamedica, 1m-Kaliumchlorid-Lösung Fresenius
- Denmark · Alkacit, Kaleorid
- Estonia · Potassium Chloride Braun, Potassium Chloride Kabi
- Spain · Acalka, Acetato De Potasio B.Braun
- Finland · Addex-Kaliumklorid, Alkacit
- France · Chlorure De Potassium B. Braun, Chlorure De Potassium Cooper
- United Kingdom (Northern Ireland) · Cystopurin, Kay-Cee-L
- Greece · Potassium Chloride Demo Αβεε, Potassium Chloride Noridem
- Croatia · 1 M Kalijev Klorid Hztm, Kalijev Klorid B. Braun
- Hungary · Kaldyum, Kalii Citratis Fono Viii. Naturland
- Ireland · Cystopurin, Kacital
- Iceland · Alkacit, Kaleorid
- Italy · Kcl-Retard, Lento-Kalium
- Lithuania · Potassium Chloride Braun, Potassium Chloride Fresenius
- Luxembourg · Kalinor-Retard P, Kaliumchlorid Braun
- Latvia · Potassium Chloride Braun, Potassium Chloride Kabi
- Malta · Cystopurin, Potassium Chloride Monico
- Netherlands · Kacital, Kaliumchloride
- Norway · Addex, Addex Kaliumklorid
- Poland · Kaldyum, Kalipoz Prolongatum
- Portugal · Acalka, Cloreto De Potássio Basi
- Romania · Clorură De Potasiu Braun, Clorură De Potasiu Kabi
- Sweden · Addens-Kaliumklorid B. Braun, Addex-Kaliumklorid
- Slovenia · Kalijev Klorid B. Braun, Kalijev Klorid Jadran
- Slovakia · Kaldyum, Kalium Chloratum Biomedica
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FDA National Drug Code directory (United States). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/ad8551b7-4a4b-48ad-9427-125b160d8d35 GET /v1/drugs/ad8551b7-4a4b-48ad-9427-125b160d8d35?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"unii": {
"unii": "660YQ98I10",
"rxcui": "8591",
"inchikey": "WCUXLLCKKVVCTQ-UHFFFAOYSA-M",
"display_name": "POTASSIUM CHLORIDE",
"substance_type": "chemical",
"ingredient_type": "INGREDIENT SUBSTANCE"
},
"route": "ORAL",
"spl_meta": {
"ff67f638-5b53-406a-962a-87773a91fc48": {
"match": "brand_token",
"title": "POTASSIUM CITRATE TABLET, EXTENDED RELEASE [BRYANT RANCH PREPACK]",
"spl_version": "104",
"published_date": "2026-05-28"
}
},
"productid": "70518-4050_3fa16c36-fa12-db93-e063-6394a90ad2bf",
"productndc": "70518-4050",
"dosage_form": "CAPSULE, EXTENDED RELEASE",
"orange_book": {
"appl_no": "214686",
"products": [
{
"rs": false,
"rld": false,
"te_code": "AB",
"strength": "8MEQ",
"product_no": "001",
"approval_date": "Feb 16, 2021"
},
{
"rs": false,
"rld": false,
"te_code": "AB",
"strength": "10MEQ",
"product_no": "002",
"approval_date": "Feb 16, 2021"
}
],
"appl_type": "A"
},
"dea_schedule": null,
"product_type": "HUMAN PRESCRIPTION DRUG",
"substance_name": "POTASSIUM CHLORIDE",
"shortage_reason": "Potassium Citrate Tablet, Extended Release",
"shortage_status": "current",
"proprietary_name": "Potassium Chloride",
"active_ingred_unit": "mg/1",
"application_number": "ANDA214686",
"marketing_category": "ANDA",
"nonproprietary_name": "Potassium Chloride",
"start_marketing_date": "20240411",
"active_numerator_strength": "750"
}See everything about kalium, kombinationen.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.